The BEST1 gene bestrophinopathy genetic test is a specialized diagnostic tool used to detect mutations in the BEST1 gene, which are associated with a group of eye disorders known as bestrophinopathies. These disorders can lead to a range of visual impairments, including reduced vision, distorted vision, and in some cases, progressive loss of vision. The conditions linked to mutations in the BEST1 gene include Best vitelliform macular dystrophy, adult-onset vitelliform macular dystrophy, autosomal dominant vitreoretinochoroidopathy, and autosomal recessive bestrophinopathy.
This genetic test is performed to confirm a diagnosis, guide treatment plans, and provide information for family planning. It involves analyzing the patient's DNA to identify any mutations in the BEST1 gene that may be responsible for the development of bestrophinopathies.
The test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the BEST1 gene bestrophinopathy genetic test is 4400 AED. This price may cover the collection of the sample, usually through a blood draw or cheek swab, the genetic analysis, and a detailed report explaining the results. It is advisable for patients to consult with a healthcare provider or a genetic counselor before and after undergoing genetic testing to understand the implications of the test results fully.
The CYP4V2 Gene Bietti Crystalline Corneoretinal Dystrophy Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the CYP4V2 gene, which are linked to Bietti Crystalline Corneoretinal Dystrophy (BCD). BCD is a rare genetic eye disorder characterized by the progressive loss of vision, the presence of crystal-like deposits in the retina, and the degeneration of the retina and choroid. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect specific genetic alterations in the CYP4V2 gene, helping in the diagnosis and management of the condition. By identifying the genetic basis of BCD, this test plays a crucial role in understanding the risk of disease progression, potential treatment approaches, and the likelihood of passing the condition to future generations.
The FOXL2 gene test is a specialized genetic analysis designed to diagnose conditions associated with mutations in the FOXL2 gene, notably Blepharophimosis, Epicanthus Inversus, and Ptosis (BPES). BPES is a rare genetic disorder that affects the development of the eyes and eyelids, leading to distinctive facial features. The condition is characterized by a narrowing of the eye opening (blepharophimosis), an inward folding of the skin of the upper eyelid (epicanthus inversus), and drooping of the upper eyelids (ptosis). In some cases, BPES can also impact ovarian function, leading to premature ovarian failure in women.
The FOXL2 gene test involves analyzing the patient's DNA to identify mutations in the FOXL2 gene, which plays a crucial role in eyelid and ovarian development. Identifying mutations in this gene can confirm a diagnosis of BPES, assist in understanding the risk of passing the condition to offspring, and guide management and treatment decisions.
In the United Arab Emirates, DNA Labs UAE offers this genetic test at a cost of 4400 AED. DNA Labs UAE is known for its advanced genetic testing services, providing accurate and reliable results. The test is conducted in a state-of-the-art laboratory by a team of specialized geneticists and healthcare professionals, ensuring high-quality standards and confidentiality of patient information.
The UBE3B Gene Blepharophimosis-Ptosis-Intellectual Disability Syndrome Genetic Test is a specialized diagnostic tool used to identify mutations in the UBE3B gene, which are linked to a rare genetic disorder. This condition is characterized by a combination of facial anomalies including blepharophimosis (a condition where the eyelids are horizontally shortened), ptosis (drooping of the upper eyelid), and intellectual disability among other possible features.
DNA Labs UAE offers this comprehensive genetic test to help in the diagnosis and management of individuals suspected of having this syndrome. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific mutations in the UBE3B gene that are known to cause the disorder.
The cost of the UBE3B Gene Blepharophimosis-Ptosis-Intellectual Disability Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This investment can be crucial for affected families, providing them with a definitive diagnosis and enabling healthcare providers to tailor management and support strategies to the individual's needs, potentially improving quality of life and outcomes.
The RLBP1 Gene Bothnia Retinal Dystrophy Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the RLBP1 gene, which are associated with Bothnia Retinal Dystrophy. This genetic condition is a form of retinal dystrophy that predominantly affects vision, leading to symptoms such as night blindness and progressive loss of visual fields. Early and accurate diagnosis through genetic testing is crucial for the management and understanding of the condition, allowing affected individuals and their families to make informed decisions regarding treatment and lifestyle adjustments.
The test is priced at 4400 AED and involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific genetic mutations in the RLBP1 gene. DNA Labs UAE, where this test is conducted, is equipped with state-of-the-art technology and staffed by experienced professionals to ensure accurate and reliable results.
The RGS9 Gene Bradyopsia Genetic Test is a specialized diagnostic procedure designed to identify mutations in the RGS9 gene, which are responsible for the rare condition known as bradyopsia. Bradyopsia is characterized by a delayed adaptation of the eyes to changes in light, resulting in temporary blindness or impaired vision when transitioning between different lighting conditions. This condition affects the speed at which the retina can reset and respond to visual stimuli, leading to difficulties in activities that involve sudden changes in light, such as driving at night or entering a dimly lit room.
The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities in the RGS9 gene. Identifying these mutations can be crucial for understanding the cause of vision problems in affected individuals and can aid in the development of personalized management strategies to cope with the condition.
Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities and state-of-the-art technology, the RGS9 Gene Bradyopsia Genetic Test is priced at 4400 AED. DNA Labs UAE provides a comprehensive service, including pre-test counseling, sample collection, and detailed post-test analysis and advice, ensuring that patients receive not only accurate results but also the support and information they need to understand and manage their condition effectively.
The RGS9BP Gene Bradyopsia Genetic Test is a specialized genetic assessment conducted to diagnose bradyopsia, a rare inherited eye condition characterized by a delayed adaptation of the eyes to changes in light intensity. Individuals with bradyopsia experience difficulty adjusting from brightly lit environments to darker ones, or vice versa, which can significantly impact daily activities and quality of life. The condition is linked to mutations in the RGS9BP gene, which plays a crucial role in the visual phototransduction pathway.
This genetic test involves analyzing the patient's DNA to identify mutations in the RGS9BP gene that are responsible for bradyopsia. Early diagnosis through genetic testing can be crucial for managing symptoms and implementing strategies to cope with the visual impairment caused by this condition.
The test is available at DNA Labs UAE, a leading facility in genetic diagnostics and research. The cost of the RGS9BP Gene Bradyopsia Genetic Test is 4400 AED. This comprehensive testing service provides individuals and healthcare providers with critical information for the diagnosis and potential management of bradyopsia, enabling affected individuals to better understand their condition and live more comfortably with its implications.
The EYA1 gene test for Branchiootorenal Syndrome Type 1 is a specialized genetic test available at DNA Labs UAE. Priced at 4400 AED, this diagnostic tool is crucial for identifying mutations in the EYA1 gene, which are responsible for the development of Branchiootorenal Syndrome Type 1. This condition is characterized by an array of symptoms including branchial arch anomalies, hearing loss, and renal abnormalities. Early detection through this test can facilitate timely intervention and management of the syndrome. DNA Labs UAE employs state-of-the-art technology to ensure accurate and reliable results, aiding in the better understanding and treatment planning for affected individuals and their families.
The SIX5 Gene Branchiootorenal Syndrome Type 2 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the SIX5 gene, which are associated with Branchiootorenal Syndrome Type 2 (BOR2). BOR2 is a genetic condition characterized by developmental abnormalities affecting the ears, neck, and kidneys. Symptoms can vary widely among individuals but may include hearing loss, branchial cysts, renal anomalies, and other related issues.
This test is crucial for individuals with a family history of BOR2 or those exhibiting symptoms, as early diagnosis can lead to better management and treatment of the condition. The process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the lab for genetic mutations in the SIX5 gene.
At DNA Labs UAE, the cost for the SIX5 Gene Branchiootorenal Syndrome Type 2 Genetic Test is set at 4400 AED. The price reflects the sophisticated technology and expertise required to accurately identify mutations in the gene of interest. By opting for this test, patients gain crucial insights into their genetic makeup, empowering them with the knowledge to make informed decisions about their health and the management of BOR2.
The ZNF469 gene plays a crucial role in the structural integrity of the cornea, and mutations in this gene can lead to Brittle Cornea Syndrome (BCS), a rare genetic disorder characterized by thinning and increased fragility of the cornea that can lead to severe visual impairment. The ZNF469 Gene Brittle Cornea Syndrome Genetic Test is a specialized diagnostic tool designed to detect mutations in the ZNF469 gene, aiding in the diagnosis of BCS. This test is crucial for individuals with a family history of BCS or those exhibiting symptoms, as early diagnosis can lead to interventions that may preserve vision and prevent complications.
The test is available at DNA Labs UAE, a leading genetic testing facility known for its state-of-the-art technology and expertise in genetic diagnostics. The cost of the ZNF469 Gene Brittle Cornea Syndrome Genetic Test is 4400 AED. This investment covers the comprehensive analysis required to accurately identify the presence of ZNF469 gene mutations. Given the complexity and rarity of the condition, having access to such a targeted genetic test is invaluable for affected individuals and their families, offering them a clear path towards understanding their condition and exploring potential management strategies.
